After completing this activity, pharmacists should be able to:
- Outline the treatment for gastro-oesophageal reflux disease (GORD)
- Describe the options for tapering the dose of proton pump inhibitors (PPIs) and management of mild to moderate GORD symptoms
- Describe the evidence supporting the use of over the counter medicines for addressing breakthrough GORD symptoms when taking PPIs
2016 Competency Standards Addressed: 3.1, 3.2, 3.5
Accreditation number: A2008RP1 Accreditation expires: 31/07/2022
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.